|
|
Volumn 34, Issue 5, 2002, Pages 1970-1971
|
|
Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 2 RECEPTOR ANTIBODY;
STEROID;
TACROLIMUS;
BASILIXIMAB;
CORTICOSTEROID;
DRUG DERIVATIVE;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
BACTERIAL INFECTION;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
LIVER TRANSPLANTATION;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
ARTICLE;
CHILD;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
IMMUNOLOGY;
MALE;
MORTALITY;
PHYSIOLOGY;
PRESCHOOL CHILD;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TIME;
ADRENAL CORTEX HORMONES;
ANTIBODIES, MONOCLONAL;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MYCOPHENOLIC ACID;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
HUMANS;
RECOMBINANT FUSION PROTEINS;
|
|
EID: 0035993838
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03144-5 Document Type: Conference Paper |
|
Times cited : (19)
|
|
References (3)
|
